Recognizing seizures in the intensive care unit
Official title: Seizure Semiology Identification and Agreement in the Intensive Care Setting: How do Clinical Scientists Compare to Other Healthcare Professionals (Intensivists, Neurologists, ITU Nurses and Neurophysiologists) in Identifying and Interpreting Clinical Signs in Patients on the Adult Intensive Care Unit
Run by Nottingham University Hospitals NHS Trust · NCT07136298 · Data updated 2026-11-12
This project tests how well NHS neurophysiology scientists, neurologists, intensivists, and ICU nurses can identify seizures from digital video recordings of ICU events.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Nottingham University Hospitals NHS Trust Academic / other |
| Locations | 1 site (Nottingham, Nottinghamshire) |
| Status | Recruiting |
| Started | March 3, 2025 |
| Main results expected | August 31, 2025 |
| Study ends | August 31, 2025 |
| Registry record updated | August 22, 2025 |
| Trial ID | NCT07136298 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal participants are NUH-employed neurophysiology scientists (Band 7+ or CCT holders with ≥1 year adult ICU experience), neurologists and intensivists with ≥1 year covering ICU, and ICU nurses with ≥1 year experience.
✕Probably not a fit
Patients outside the adult ICU or those whose care already depends on continuous EEG confirmation rather than bedside visual recognition are unlikely to benefit directly from this work.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational project shows digital video recordings of clinical events on the adult ICU to different groups of NHS staff and asks them to classify which events are seizures versus other movements. Participants are drawn from neurophysiology scientists, neurologists, intensivists, and ICU nurses employed at Nottingham University Hospitals with relevant ICU experience. Raters view videos without accompanying clinical notes and their classifications will be compared to a reference standard (for example concurrent EEG or expert consensus) to measure accuracy. Results will be analyzed to compare performance and common misclassification patterns across staff groups.
Why it matters
Potential benefit: If successful, the results could help improve bedside recognition of seizures in the ICU and reduce delays or unnecessary treatments by informing training or diagnostic pathways.
How similar studies have gone: Prior small studies have shown poor concordance between video-only impressions and EEG-confirmed seizures and mixed differences between staff groups, so the approach has precedent but variable results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Staff working at Nottingham University Hospitals (NUH) in one of the following staff groups; * Neurophysiology Scientists/Clinical Physiologists at Band 7 level and above, * Neurophysiologists who have completed the CCT in Neurophysiology with at least 1 year of Adult ICU experience. * members of the Neurology medical team with at least 1 years' experience of covering ITU * Intensivists with at least 1 year's experience working on the Adult intensive care unit * Nursing staff working on the Intensive care unit with at least 1 year's experience Exclusion Criteria: * Staff not employed by NUH i.e. agency staff * Staff in other groups not mentioned above
Where it's running
-
Nottingham University Hospitals
Nottingham, Nottinghamshire, United Kingdom Recruiting
Study contacts
- Study coordinator: James S Baird
- Email: james.baird@nhs.net
- Phone: 01159709146
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Levetiracetam to prevent seizures in adults with Down syndrome and Alzheimer's disease
This trial will test whether the anti-seizure medicine levetiracetam can prevent tonic-clonic seizures and slow cognitive decline in adults over 40 who have Down syndrome and symptomatic Alzheimer's disease.
-
Preventing first seizures with levetiracetam in patients with motor cortex brain metastases
This test will try giving levetiracetam to adults with motor cortex brain metastases who have never had a seizure to see if it prevents a first seizure compared with not giving the drug.
-
Preventing early seizures after traumatic brain injury
This randomized study will test whether phenytoin, levetiracetam, or placebo best prevent early seizures in people hospitalized with moderate-to-severe traumatic brain injury.
-
Wearable device for detecting seizures
This study tests a new wearable device for detecting seizures in people with epilepsy to see if it works well and can help them feel more comfortable in their daily lives.
-
Registry for patients with thyroid hormone resistance
This study is collecting information from patients with thyroid hormone resistance to see how their specific gene mutations affect their health and improve diagnosis and treatment.
-
Comparing short and long-term use of levetiracetam for seizures in brain tumor patients
This study tests whether taking levetiracetam for a shorter time can help brain tumor patients with seizures just as well as the standard longer treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.